Hims & Hers obtains YourBio's microsampling tech, which the firm said will speed its efforts to improve blood collection, including outside traditional clinical settings.
The company is developing a noninvasive urine-based test for sexually transmitted infections including chlamydia and gonorrhea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback